. Author manuscript; available in PMC: 2015 May 23.

Published in final edited form as: Muscle Nerve. 2011 May 23;44(1):20–24. doi: 10.1002/mus.22114

Table 3.

Baseline disease severity measures by quartile of LDL/HDL ratio.

	LDL/HDL ratio <1.82	LDL/HDL ratio 1.82–2.27	LDL/HDL ratio 2.28–2.95	LDL/HDL ratio >2.95	ANOVA P-value
Number of subjects	106	108	105	108
Total ALSFRS-R	33.46 (8.51)	36.17 (9.42)	37.51 (9.06)	38.66 (7.92)	0.0002
FVC	82.56 (18.67)	84.35 (22.86)	88.39 (20.04)	86.19 (16.97)	0.2
BMI	24.71 (5.35)	26.67 (5.27)	29.08 (13.22)	29.34 (17.70)	0.01
Age	57.72 (12.38)	55.71 (14.47)	53.81 (11.27)	51.71 (11.78)	0.004

Data expressed as mean and standard deviation (SD). LDL, low-density lipoprotein; HDL, high-density lipoprotein; ANOVA, analysis of variance; ALSFRS-R, ALS Functional Rating Scale—revised; FVC, functional vital capacity (percent of predicted); BMI, body mass index. P-values calculated by ANOVA across all quartiles.